help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wickelgren, R. B.
Right arrow Articles by Carlsson, L. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wickelgren, R. B.
Right arrow Articles by Carlsson, L. M.

Journal of Clinical Endocrinology & Metabolism, Vol 80, 2154-2157, Copyright © 1995 by Endocrine Society


ARTICLES

Expression of exon 3-retaining and exon 3-excluding isoforms of the human growth hormone-receptor is regulated in an interindividual, rather than a tissue-specific, manner

RB Wickelgren, KL Landin, C Ohlsson and LM Carlsson
Department of Internal Medicine, Sahlgrenska, Hospital, University of Goteborg, Sweden.

GH has multiple effects on growth and metabolism, and these functions are mediated through binding to specific cell surface receptors. The human GH receptor (GHR) exists in two known isoforms; in one form exon 3 is present (GHR3+), and in the other, exon 3 is absent (GHR3-). Recent reports have suggested that the expression of the two isoforms is tissue specific and/or developmentally regulated. We used a reverse transcription-polymerase chain reaction assay to study the expression pattern of the two isoforms in a variety of tissues from normal subjects and patients with acromegaly. In skeletal muscle from both normal subjects and patients with acromegaly, the GHR3+ transcript was expressed, either alone or together with the shorter (GHR3-) transcript. When multiple tissues from six subjects were tested, the expression of the two isoforms varied among subjects, whereas different tissues from the same subject showed the same expression pattern. These results indicate that the expression of the GHR isoforms is not tissue specific. Instead, the expression of the GHR isoforms appears to be specific for each individual, suggesting that it is under the control of factors that affect all tissues in the body.


This article has been cited by other articles:


Home page
J EndocrinolHome page
G. Kenth, J. A M. Mergelas, and C. G. Goodyer
Developmental changes in the human GH receptor and its signal transduction pathways
J. Endocrinol., July 1, 2008; 198(1): 71 - 82.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
G. Kenth, Z. Shao, D. E. C. Cole, and C. G. Goodyer
Relationship of the Human Growth Hormone Receptor Exon 3 Genotype with Final Adult Height and Bone Mineral Density
J. Clin. Endocrinol. Metab., February 1, 2007; 92(2): 725 - 728.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
L. J. Woodhouse, A. Mukherjee, S. M. Shalet, and S. Ezzat
The Influence of Growth Hormone Status on Physical Impairments, Functional Limitations, and Health-Related Quality of Life in Adults
Endocr. Rev., May 1, 2006; 27(3): 287 - 317.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
M.-C. Lacroix, J. Guibourdenche, T. Fournier, I. Laurendeau, A. Igout, V. Goffin, J. Pantel, V. Tsatsaris, and D. Evain-Brion
Stimulation of Human Trophoblast Invasion by Placental Growth Hormone
Endocrinology, May 1, 2005; 146(5): 2434 - 2444.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
J. Pantel, J. Grulich-Henn, M. Bettendorf, C. J. Strasburger, U. Heinrich, and S. Amselem
Heterozygous Nonsense Mutation in Exon 3 of the Growth Hormone Receptor (GHR) in Severe GH Insensitivity (Laron Syndrome) and the Issue of the Origin and Function of the GHRd3 Isoform
J. Clin. Endocrinol. Metab., April 1, 2003; 88(4): 1705 - 1710.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
C. G. Goodyer, R. M. O. Figueiredo, S. Krackovitch, L. De Souza Li, J. A. Manalo, and G. Zogopoulos
Characterization of the growth hormone receptor in human dermal fibroblasts and liver during development
Am J Physiol Endocrinol Metab, December 1, 2001; 281(6): E1213 - E1220.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
M. Gebre-Medhin, L.-G. Kindblom, H. Wennbo, J. Tornell, and J. M. Meis-Kindblom
Growth Hormone Receptor Is Expressed in Human Breast Cancer
Am. J. Pathol., April 1, 2001; 158(4): 1217 - 1222.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
A. Edens and F. Talamantes
Alternative Processing of Growth Hormone Receptor Transcripts
Endocr. Rev., October 1, 1998; 19(5): 559 - 582.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
J. S. Freeth, R. M. Ayling, A. J. Whatmore, P. Towner, D. A. Price, M. R. Norman, and P. E. Clayton
Human Skin Fibroblasts as a Model of Growth Hormone (GH) Action in GH Receptor-Positive Laron's Syndrome
Endocrinology, January 1, 1997; 138(1): 55 - 61.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Pantel, K. Machinis, M.-L. Sobrier, P. Duquesnoy, M. Goossens, and S. Amselem
Species-specific Alternative Splice Mimicry at the Growth Hormone Receptor Locus Revealed by the Lineage of Retroelements during Primate Evolution. A NOVEL MECHANISM ACCOUNTING FOR PROTEIN DIVERSITY BETWEEN AND WITHIN SPECIES
J. Biol. Chem., June 16, 2000; 275(25): 18664 - 18669.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1995 by The Endocrine Society